ELF would like to invite representatives from patient organisations to input into the recently launched International Respiratory Coalition (IRC).
The International Respiratory Coalition (IRC) was launched by European Respiratory Society (ERS) together with the Global Allergy & Airways Patient Platform (GAAPP), AstraZeneca and Amgen in September 2021 at the ERS Congress. The IRC will be a multistakeholder initiative and will be open for all to join.
The overall aim of the IRC is to promote lung health and improve respiratory care. The vision is for every country to have the tools to implement a national respiratory strategy based on best practice.
ELF and GAAPP want to ensure that this initiative has patients at its heart. Therefore, in parallel with the ERS carrying out a survey with national respiratory societies, we would like to get the views and input of patient organisations.
The survey has 13 questions and the answers you give will help inform the strategy and activities of the IRC.
Complete the short survey by 4 January 2022: https://www.surveymonkey.co.uk/r/IRC-patient-orgs
Find out more about the IRC: https://www.ersnet.org/advocacy/international-respiratory-coalition/
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79